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Abstract The single nucleotide polymorphism (SNP)
rs7566605 in the upstream region of the insulin-induced
gene 2 (INSIG2) is associated with the obesity phenotype in
many Caucasian populations. In Japanese, this association
with the obesity phenotype is not clear. To investigate the
relationship between rs7566605 and obesity in Japanese, we
genotyped rs7566605 from severely obese subjects [n =
908, body mass index (BMI) C 30 kg/m
2] and normal-
weight control subjects (n = 1495, BMI \ 25 kg/m
2). A
case–control association analysis revealed that rs7566605
was signiﬁcantly associated with obesity in Japanese. The P
value in the minor allele recessive mode was 0.00020, and
the odds ratio (OR) adjusted for gender and age was 1.61
[95% conﬁdential interval (CI) = 1.24–2.09]. Obesity-
associated phenotypes, which included the level of
BMI, plasma glucose, hemoglobin A1c, total cholesterol,
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and blood pressure, were not associated with the rs7566605
genotype. Thus, rs7566605 in the upstream region of the
INSIG2 gene was found to be associated with obesity, i.e.,
severe obesity, in Japanese.
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Introduction
Obesity has become one of the major issues in public
health, medicine, and the economy (Kopelman 2000).
Obesity is considered to be important due to its relationship
with various complications, such as diabetes mellitus,
dyslipidemia, and hypertension. A combination of these
dysfunctions is now deﬁned as the metabolic syndrome that
signiﬁcantly increases the risk of cardiovascular disease
(Wilson and Grundy 2003). Genetic and environmental
factors contribute to the development of obesity (Maes
et al. 1997; Barsh et al. 2000; Rankinen et al. 2006). Due to
the recent progress in single nucleotide polymorphism
(SNP) genotyping techniques, it is possible to conduct
genome-wide screens to identify common genetic variants
associated with obesity. We conducted a large-scale case–
control association study and found that secretogranin III
(SCG3) (Tanabe et al. 2007) and myotubularin-related
protein 9 (MTMR9) (Yanagiya et al. 2007) confer suscep-
tibility to the obesity phenotype in the Japanese population.
Genome-wide association studies have shown that varia-
tions in the upstream region of the insulin-induced gene 2
(INSIG2) (Herbert et al. 2006) and in the fat-mass and
obesity-associated gene (FTO) (Frayling et al. 2007;
Scuteri et al. 2007; Hinney et al. 2007) are associated with
the obesity phenotype. We recently reported the association
between variations in the FTO gene and severe obesity in
Japanese (Hotta et al. 2008). An association between
rs7566605 in the upstream region of the INSIG2 gene and
obesity was also found in several Caucasian and Hispanic
American populations (Herbert et al. 2006; Hall et al. 2006;
Lyon et al. 2007; Liu et al. 2008). However, results from
some reports with respect to these associations could not be
reproduced (Lyon et al. 2007; Smith et al. 2007; Boes et al.
2008); further, these associations are not observed in the
Indian (Kumar et al. 2007), Chinese (Yang et al. 2008) and
Japanese populations (Tabara et al. 2008). Thus, the asso-
ciation between rs7566605 in the INSIG2 gene and obesity
in Japanese remains controversial.
To investigate the relationship between the INSIG2 gene
and obesity in Japanese, we performed a case–control
association study involving patients with severe adult
obesity (BMI C 30 kg/m
2) and normal weight controls
(BMI\25 kg/m
2). We found that rs7566605 was signiﬁ-
cantly associated with severe adult obesity.
Materials and methods
Study subjects
Severely obese subjects were recruited from among the
outpatients of medical institutes. Patients with secondary
obesity and obesity-related hereditary disorders were
excluded from this study, as were patients with medication-
induced obesity. Control subjects were recruited from
among subjects who had undergone a medical examination
forthescreeningofcommondiseases.Eachsubjectprovided
written informed consent, and the protocol was approved by
the ethics committee of each institution and that of RIKEN.
The sample size for the severely obese subjects (BMI C 30
kg/m
2) was 908 (male:female ratio, 418:590; age, 49.1 ±
14.2 years; BMI, 34.5 ± 5.4 kg/m
2), whereas that for the
normal weight controls (BMI\25 kg/m
2) was 1,495 (male:
female ratio, 672:823; age, 48.1 ± 16.5 years; BMI, 21.6 ±
2.1 kg/m
2). Subjects’ clinical features are illustrated in
Table 1.
DNA preparation and SNP genotyping
Genomic DNA was prepared from the blood samples of
each subject with a Genomix kit (Talent Srl, Trieste, Italy).
SNP rs7566605 reported in a previous genome-wide
association study (Herbert et al. 2006) was genotyped with
TaqMan probe (C_29404113_20; Applied Biosystems;
Foster City, CA, USA).
Statistical analysis
Genotype or allele frequencise were compared between
cases and controls in three different modes. In the ﬁrst
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123mode, i.e, the allele frequency mode, allele frequencies
were compared with a 2 9 2 contingency table. In the
second mode, i.e., the minor allele recessive mode, fre-
quencies of the homozygous genotype for the minor allele
were compared with a 2 9 2 contingency table. In the third
mode, i.e., the minor allele dominant mode, frequencies
of the homozygous genotype for the major allele were
compared with a 2 9 2 contingency table. A test of
independence was performed using Pearson’s v
2 method.
Odds ratio (OR) and 95% conﬁdence interval (CI) were
calculated by Woolf’s method. The rs7566605 genotype
was transformed to a multidichotomous variable, i.e.,
homozygosity with C alleles versus the other genotypes.
The OR adjusted for age and gender was calculated by
multiple logistic regression analysis, with genotype, age,
and gender as independent variables. Hardy–Weinberg
equilibrium was assessed using the v
2 test (Nielsen et al.
1998). A simple comparison of clinical data among the
different genotypes was performed by one-way analysis of
variance (ANOVA). Statistical analyses were performed
with StatView 5.0 (SAS Institute Inc., Cary, NC, USA).
Results
Case–control association study
We successfully genotyped rs7566605 by the TaqMan
assay and performed tests of independence between the
phenotype and genotype of obesity in severely obese
subjects (BMI C 30 kg/m
2) and normal weight controls
(BMI\25 kg/m
2). The minor allele frequency (MAF) of
rs7566605 in the control group was 0.31. This was con-
sistent with data obtained from the haplotype map of the
human genome (HapMap). As shown in Table 2,
rs7566605 demonstrated signiﬁcant association with the
obesity phenotype [recessive mode, P = 0.00020, and the
OR (95% CI) was 1.62 (1.26–2.10)]. The rs7566605
genotype was transformed to a multidichotomous variable,
i.e., CC homozygote versus the other genotypes. Multiple
logistic regression analysis was performed, with genotype,
age, and gender as independent variables. The P values for
age, gender, and genotype were 0.21, 0.51, and 0.00030,
respectively. OR (95% CI) was 1.61 (1.24–2.09). Our data
indicated that rs7566605 in the INSIG2 gene was associ-
ated with severe obesity in Japanese.
A deviation from the Hardy–Weinberg equilibrium was
detected in cases (P = 0.0015), because this SNP is asso-
ciated with obesity and cases were selected by phenotype.
Cases were selected on the basis of BMI, and the preva-
lence of subjects with a BMI C30 kg/m
2 is only 2–3% in
Japan (Yoshiike et al. 2002). Cases may be biased and not
representative of the general population. Thus, it is not
unexpected that cases were not in accordance with Hardy–
Weinberg equilibrium.
Analysis of various quantitative phenotypes
with rs7566605
To investigate whether the genotypes of SNP rs7566605
are associated with the phenotypes of metabolic disorders,
we compared the following among the different genotypes
in cases, controls, and combined groups: ANOVA results;
BMI; levels of fasting plasma glucose; hemoglobin A1c
(HbA1c); total cholesterol, triglycerides, and high-density
lipoprotein (HDL) cholesterol; and blood pressure. Quan-
titative phenotypes with respect to BMI and levels of
fasting plasma glucose; HbA1c; total cholesterol, triglyc-
erides, and HDL cholesterol; and blood pressure were not
found to be signiﬁcantly associated with the rs7566605
genotypes in either cases or controls (Table 3). Systolic
and diastolic blood pressures were signiﬁcantly lower in
the GG homozygote in the control group. Blood pressure
was higher in GG homozygote in the obese group. Thus,
the rs7566605 genotype was not associated with blood
pressure.
Table 1 Clinical
characterization of obese and
control subjects
Data are mean ± standard
deviation
HbA1c hemoglobin A1c, HDL
high-density lipoprotein
a P values were analyzed using
Mann–Whitney U test
Obese Control P value
a
Sample size 908 1495 –
Gender (M/F) 418/490 672/823 –
Age (year) 49.1 ± 14.2 48.1 ± 16.5 0.050
BMI (kg/m
2) 34.50 ± 5.39 21.65 ± 2.07 \0.000001
Glucose (mg/dl) 129.1 ± 49.7 97.7 ± 23.8 \0.000001
HbA1c (%) 6.5 ± 1.8 5.1 ± 0.6 \0.000001
Total cholesterol (mg/dl) 210.1 ± 38.0 201.2 ± 36.4 \0.000001
Triglycerides (mg/dl) 155.6 ± 111.0 104.0 ± 73.1 \0.000001
HDL cholesterol (mg/dl) 53.1 ± 18.8 65.1 ± 15.6 \0.000001
Systolic blood pressure (mmHg) 136.4 ± 18.2 123.4 ± 17.8 \0.000001
Diastolic blood pressure (mmHg) 83.8 ± 12.0 76.0 ± 11.1 \0.000001
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Recent genome-wide association studies have shown that
rs7566605 in the upstream region of the INSIG2 gene is
associated with obesity (Herbert et al. 2006). Associations
between rs7566605 and the obesity phenotype have been
observed in many Caucasian subjects (Herbert et al. 2006;
Hall et al. 2006; Lyon et al. 2007; Liu et al. 2008). How-
ever, these associations were controversial with regard to
Asian subjects (Yang et al. 2008; Tabara et al. 2008). The
association between rs7566605 and BMI may be hard to be
replicated in the Asian general population due to the rel-
atively smaller average BMI value and smaller proportion
of obesity with BMI[30 kg/m
2 in Asians compared with
Table 2 Association of rs7566605 in the INSIG2 gene with severe obesity
Sample (sample size) No. of subjects (%) No. of chromosomes (%) HWE test
a
CC CG GG C G v
2 P value
Case (n = 908) 127 (14) 365 (40) 416 (46) 619 (34) 1,197 (66) 10.1 0.0015
Control (n = 1495) 136 (9) 664 (44) 695 (46) 936 (31) 2,054 (69) 1.6 0.21
Allele frequency mode
b Minor allele recessive mode
b Minor allele dominant mode
b
v
2 P value OR
c (95% CI) v
2 P value OR
c (95% CI) v
2 P value OR
c (95% CI)
4.0 0.046 1.13 (1.00–1.28) 13.9 0.00020 1.62 (1.26–2.10) 0.1 0.75 1.03 (0.87–1.21)
a Hardy–Weinberg equilibrium test
b Association test was performed in three different modes as described in the ‘‘Materials and methods’’, and the results in the three modes are
shown
c Odds ratio (OR) with 95% conﬁdence interval (CI)
Table 3 Comparison of various quantitative phenotypes among different genotypes at rs7566605 in obese and control subjects
Obese
a Control
a
CC (n = 127) CG (n = 365) GG (n = 416) CC (n = 136) CG (n = 664) GG (n = 695)
Age (year) 48.5 ± 15.2 48.0 ± 14.0 50.0 ± 14.2 47.7 ± 17.4 48.1 ± 16.7 48.4 ± 16.4
P value
b 0.13 0.89
BMI (kg/m
2) 35.22 ± 6.91 34.28 ± 5.09 34.52 ± 5.21 21.70 ± 2.06 21.68 ± 2.07 21.60 ± 2.10
P value 0.25 0.73
Glucose (mg/dl) 127.8 ± 44.1 129.3 ± 50.3 129.1 ± 50.8 102.0 ± 40.6 98.0 ± 21.7 97.0 ± 21.9
P value 0.96 0.23
HbA1c (%) 6.4 ± 1.7 6.5 ± 1.8 6.5 ± 1.8 5.1 ± 0.8 5.1 ± 0.6 5.1 ± 0.6
P value 0.93 0.81
Total cholesterol (mg/dl) 209.1 ± 39.3 209.3 ± 37.5 210.4 ± 38.1 204.1 ± 35.0 199.4 ± 36.9 202.2 ± 36.3
P value 0.90 0.23
Triglycerides (mg/dl) 147.1 ± 85.4 160.1 ± 127.3 153.9 ± 102.7 99.6 ± 58.2 103.0 ± 65.5 105.6 ± 82.3
P value 0.51 0.62
HDL cholesterol (mg/dl) 51.6 ± 14.1 52.7 ± 15.9 53.8 ± 22.2 67.3 ± 14.8 64.9 ± 15.8 65.0 ± 15.6
P value 0.52 0.45
SBP
c (mmHg) 134.8 ± 15.3 136.8 ± 18.7 136.6 ± 18.4 122.9 ± 15.8 125.4 ± 17.9 121.9 ± 18.0
P value 0.57 0.0019
DBP
d (mmHg) 82.9 ± 11.1 84.6 ± 11.7 83.4 ± 12.4 76.5 ± 11.3 77.0 ± 11.1 75.1 ± 11.1
P value 0.26 0.008
Data are mean ± standard deviation
BMI body mass index, HbA1 hemoglobin A1c, HDL high-density lipoprotein
a Data of each quantitative phenotype were compared among different genotypes at the rs7566605 in obese and control subjects
b P values were analyzed using analysis of variance in each group of obese and control subjects
c Systolic blood pressure
d Diastolic blood pressure
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123those in Caucasians. Indeed, criteria of obesity is BMI[30
kg/m
2 in Caucasians and BMI[25 kg/m
2 in Japanese. We
could show the contribution of rs7566605 to obesity in
Japanese using severely obese patients with a BMI C30 kg/
m
2 as cases. SNP rs7566605 could also contribute to the
development of severe obesity in Japanese.
Allele frequency was 0.31–0.34 in Japanese, just as
observed in European subjects, and the CC genotype was
also associated with severe obesity in Japanese, as previ-
ously reported (Herbert et al. 2006; Hall et al. 2006; Lyon
et al. 2007; Liu et al. 2008). However, CC genotype was
not signiﬁcantly associated with BMI in obese and control
groups, although CC homozygotes had higher BMI. Thus,
it is possible that our study did not have sufﬁcient power to
detect the association between rs7566605 and BMI. The
CC genotype would be thrifty variation and have an
advantage for survival before modern times. Subjects with
CC genotype would be susceptible to obesity in recent
years. As a result, the number of CC homozygotes would
increase in severely obese group, leading to a deviation
from Hardy–Weinberg equilibrium.
Since rs7566605 exists approximately 10 kb upstream
from INSIG2, SNPs may affect the transcriptional activity
of INSIG2. INSIG2 is expressed ubiquitously. It was
downregulated by insulin in the liver and involved in fatty
acid synthesis (Yabe et al. 2003; Takaishi et al. 2004).
INSIG2 also mediates feedback control of cholesterol
synthesis (Goldstein et al. 2006). Although serum total
cholesterol, HDL cholesterol, and triglycerides were not
signiﬁcantly different among genotypes, it is possible that
INSIG2 is related to obesity as it affects lipid metabolism.
In summary, our study indicated that rs7566605 in the
upstream region of the INSIG2 gene may inﬂuence the risk
of severe obesity in Japanese.
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